Cyrus S. Poonawalla | |
---|---|
Born | 1941 83) | (age
Nationality | Indian |
Education | Brihan Maharashtra College of Commerce |
Occupation(s) | Businessman, owner of Bilthoven Biologicals, Serum Institute of India, Poonawalla Fincorp |
Years active | 1966 – present |
Known for | Founder of Serum Institute of India and owner of Poonawalla Group of Companies |
Spouse | Villoo Poonawalla (died 2010) |
Children | Adar Poonawalla |
Awards | Padma Shri (2005), Padma Bhushan (2022) |
Website | cyruspoonawalla |
Cyrus S. Poonawalla (born in 1941) is an Indian billionaire businessman, and the chairman and managing director of the Cyrus Poonawalla Group, which includes the Serum Institute of India, an Indian biotech company which is the largest vaccine manufacturer in the world and Poonawalla Fincorp a leading NBFC in India. [1] [2] In 2022, he is ranked as the 4th richest person in India on Forbes India rich list with a net worth of $24.3 billion. [3] He is ranked number 1 on the Hurun Global Healthcare Rich List 2022. [4]
In October 2024, Poonawalla and his family were ranked ninth on Forbes list of India’s 100 richest tycoons, with a net worth of $24.5 billion. [5]
As per Forbes list of The Richest People In The World, dated 8 MARCH 2024, Cyrus Poonawalla ranked #90 with a net worth of $21.3 Billion. [6]
Cyrus Poonawalla was born in a Parsi (Zoroastrian) family. [7] He is the son of Soli Poonawala, who was a horse breeder. [1]
Poonawalla founded the Serum Institute of India in 1966 and built it into the largest vaccine manufacturer (by doses) in the world. Serum produces over 1.5 billion doses annually of a range of vaccines, including for measles, polio and flu. [8]
Poonawalla was married to Villoo Poonawalla, who died in 2010. [9] [10] They have a son, Adar, who currently works as the CEO of Serum Institute of India. [8] He has two grandchildren.
In May 2019, it was reported that Poonawalla, in partnership with Naum Koen, had proposed supplying Ukraine with 100 thousand doses of the measles vaccine for free vaccination. [24] [25]
Azim Hashim Premji is an Indian businessman and philanthropist, who was the chairman of Wipro Limited. Premji remains a non-executive member of the board and founder chairman. He is informally known as the Czar of the Indian IT Industry. He was responsible for guiding Wipro through four decades of diversification and growth, to finally emerge as one of the global leaders in the software industry. In 2010, he was voted among the 20 most powerful men in the world by Asiaweek. He has twice been listed among the 100 most influential people by Time magazine, once in 2004 and more recently in 2011. For years, he has been regularly listed one among The 500 Most Influential Muslims. He also serves as the Chancellor of Azim Premji University, Bangalore. Premji was awarded Padma Vibhushan, India's second highest civilian award, by the Government of India.
Pallonji Shapoorji Mistry was an Indian-born Irish billionaire businessman. He was chairman of the Shapoorji Pallonji Group and a major shareholder of India's largest private conglomerate, Tata Group.
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, India. It was founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic active pharmaceutical ingredients (APIs) that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics as well as biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
Anil Manibhai Naik is an Indian industrialist, philanthropist and the chairman emeritus of Larsen & Toubro, an Indian engineering conglomerate, and a former chairman of the National Skill Development Corporation.
Karsanbhai Khodidas Patel is an Indian billionaire businessman, industrialist and founder of the Nirma group a company with major business interests in cement, detergents, soaps and cosmetics,pharma, pkg, high chemicals, As of 2024, hurun has listed his net worth at US$ 9 billion. He has interests in education and founded Nirma University.
Kumar Mangalam Birla is an Indian businessman. He is the chairman of the Aditya Birla Group, one of the largest conglomerates in India. He is the chancellor of the Birla Institute of Technology & Science, Pilani and ex-chairman of Indian Institute of Management Ahmedabad. In 2023, Birla received the Padma Bhushan, the third highest civilian honour in India.
Kushal Pal Singh is an Indian billionaire real estate developer, and the chairman and CEO of real estate developer DLF Limited, founded by his father-in-law Chaudhary Raghvender Singh. DLF holds an estimated 10,255 acres (42 km2) of land, with about 3,000 acres (12 km2) in Gurugram, called DLF City.
Serum Institute of India (SII) is an Indian multinational biotechnology and biopharmaceuticals company, based in Pune. It is the world's largest manufacturer of vaccines by volume. It was founded by Cyrus Poonawalla in 1966 and is a part of Cyrus Poonawalla Group.
Senapathy “Kris” Gopalakrishnan is an Indian businessman and the chairman of Axilor Ventures, a startup accelerator. He is one of the co-founders of Infosys, having served as its CEO and managing director from 2007 to 2011 and vice chairman from 2011 to 2014.
Prathap Chandra Reddy is an Indian entrepreneur and cardiologist who founded the first corporate chain of hospitals in India, the Apollo Hospitals. India Today ranked him 48th in its 2017 list of India's 50 most powerful people.
Venu Srinivasan is an Indian billionaire industrialist who is the chairman emeritus of two-wheeler manufacturer TVS Motor Company and auto components manufacturer TVS Holdings. In addition, he serves on the board of Tata Sons and as one of the vice-chairmen of Tata Trusts. He received the Padma Bhushan, India's third-highest civilian award, in January 2020.
Thumbay Moideen is an Indian businessman based in Dubai, United Arab Emirates. He is the founder and president of the Thumbay Group, a diversified international business conglomerate headquartered in the Dubai International Financial Centre, with operations across 20 sectors.
Novavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland, that develops vaccines to counter serious infectious diseases. Prior to 2020, company scientists developed experimental vaccines for influenza and respiratory syncytial virus (RSV), as well as Ebola and other emerging infectious diseases. During 2020, the company redirected its efforts to focus on development and approval of its NVX-CoV2373 vaccine for COVID-19.
Niranjan Hiranandani is an Indian billionaire businessman, co-founder and managing director of Hiranandani Group, engaged in real estate business. He is ranked by Forbes among the 100 richest Indians, with a net worth of US$1.6 billion as of June 2021.
Adar Poonawalla is an Indian businessman. He is the chief executive officer of Serum Institute of India and Chairman of Poonawalla Fincorp. His father is Cyrus Poonawalla, founder of the Serum Institute of India.
Biotechnology in India is a sunrise sector within the Indian economy. Agencies of the Government of India concerned with the biotechnology industry include the Department of Biotechnology and the proposed Biotechnology Regulatory Authority of India. As of 2022, the sector is valued at $80 billion. Biotechnology in India is in a growth phase and the sector is expected to be valued at $150 billion by 2025 and surpass $300 billion in value by 2030.
Arvind Lal is an Indian billionaire, pathologist, medical administrator and the chairman and managing director of Dr Lal PathLabs, a medical diagnostic centre in Delhi. A medical graduate and a medical academic, he is reported to have modernized Indian medical diagnostics and initiated the first Public Private Partnership (PPP) in the field of laboratory testing in India. He holds the rank of a Brigadier in the Indian Armed Forces, an honorary rank conferred by the Army. The Government of India awarded him the fourth highest civilian honour of the Padma Shri, in 2009, for his contributions to Medicine.
Bharat Biotech International Limited (BBIL) is an Indian multinational biotechnology company based in Hyderabad, which is engaged in drug discovery, drug development, and the manufacture of vaccines, biotherapeutics, pharmaceuticals and healthcare products.
India began administration of COVID-19 vaccines on 16 January 2021. As of 4 March 2023, India has administered over 2.2 billion doses overall, including first, second and precautionary (booster) doses of the currently approved vaccines. In India, 95% of the eligible population (12+) has received at least one shot, and 88% of the eligible population (12+) is fully vaccinated.
Dr. Krishna Ella is an Indian scientist and entrepreneur. He is the founder and Executive Chairman of Bharat Biotech. Ella and his company were responsible for developing India's own COVID-19 vaccine, Covaxin, World's 1st clinically proven conjugated Typhoid Vaccine, TypbarTCV and ROTAVAC.